NCT03842657View on ClinicalTrials.gov

Regional Anticoagulation of Dialysis Circuits With a Calcium-free Citrate-containing Dialysate

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 5, 2019

Primary Completion Date

September 13, 2021

Study Completion Date

September 13, 2021

Conditions

Hemodialysis ComplicationBleeding

Interventions

COMBINATION_PRODUCT

anticoagulation of the dialysis circuit

Each patient included in this study will receive two heparin-free dialysis sessions with heparin-grafted membrane (control group) or RCA with calcium-free citrate-containing dialysate and calcium reinjection according to the ionic dialysance (experimental group), alternatively

Trial Locations (5)

Unknown

Pellegrin Hospital, Bordeaux

Montpellier Hospital, Montpellier

Nimes Hospital, Nîmes

Tenon Hospital, Paris

CHU Toulouse, Toulouse

All Listed Sponsors

lead

University Hospital, Toulouse

OTHER

NCT03842657 - Regional Anticoagulation of Dialysis Circuits With a Calcium-free Citrate-containing Dialysate | Biotech Hunter | Biotech Hunter